The effect of methadone and buprenorphine on human placental aromatase

Olga L. Zharikova, Sujal V. Deshmukh, Tatiana Nanovskaya, Gary Hankins, Mahmoud Ahmed

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Methadone and buprenorphine (BUP) are used for treatment of the pregnant opiate addict. CYP19/aromatase is the major placental enzyme responsible for the metabolism of methadone to 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and BUP to norbuprenorphine (norBUP). The aim of this investigation was to determine the effects of methadone and BUP on the activity of placental microsomal aromatase in the conversion of its endogenous substrates testosterone to 17β-estradiol (E2) and 16α-hydroxytestosterone (16-OHT) to estriol (E3). The conversion of testosterone and 16-OHT by human placental microsomes exhibited saturation kinetics, and the apparent Km values were 0.2 ± 1 and 6 ± 3 μM, respectively. Vmax values for E2 and E3 formation were 70 ± 16 and 28 ± 10 pmol/mg protein min, respectively. Also, data obtained revealed that methadone and BUP are competitive inhibitors of testosterone conversion to E2 and 16-OHT to E3. The K i for methadone inhibition of E2 and E3 formation were 393 ± 144 and 53 ± 28 μM, respectively, and for BUP the Ki was 36 ± 9 and 6 ± 1 μM. The higher potency of the two opiates and their metabolites in inhibiting E3 formation is in agreement with the lower affinity of 16-OHT than testosterone to aromatase. Moreover, the metabolites EDDP and norBUP were weaker inhibitors of aromatase than their parent compounds. The determined inhibition constants of methadone and BUP for E3 formation by a cDNA-expressed CYP19 preparation were similar to those for placental microsomes. Therefore, data reported here suggest that methadone, BUP, and their metabolites are inhibitors of androgen aromatization in the placental biosynthesis of estrogens.

Original languageEnglish (US)
Pages (from-to)1255-1264
Number of pages10
JournalBiochemical Pharmacology
Volume71
Issue number8
DOIs
StatePublished - Apr 14 2006

Fingerprint

Buprenorphine
Aromatase
Methadone
Testosterone
Opiate Alkaloids
Metabolites
Microsomes
Aromatization
Estriol
Aromatase Inhibitors
Biosynthesis
Metabolism
Androgens
Estradiol
Estrogens
Complementary DNA
Kinetics
Substrates
Enzymes

Keywords

  • Buprenorphine (BUP)
  • CYP19/aromatase
  • Estrogen formation
  • Human placenta
  • Methadone
  • Pregnant opiate addict

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effect of methadone and buprenorphine on human placental aromatase. / Zharikova, Olga L.; Deshmukh, Sujal V.; Nanovskaya, Tatiana; Hankins, Gary; Ahmed, Mahmoud.

In: Biochemical Pharmacology, Vol. 71, No. 8, 14.04.2006, p. 1255-1264.

Research output: Contribution to journalArticle

Zharikova, Olga L. ; Deshmukh, Sujal V. ; Nanovskaya, Tatiana ; Hankins, Gary ; Ahmed, Mahmoud. / The effect of methadone and buprenorphine on human placental aromatase. In: Biochemical Pharmacology. 2006 ; Vol. 71, No. 8. pp. 1255-1264.
@article{4f1cf9f8f8dc4efbbbaaa7e5d56e5b9a,
title = "The effect of methadone and buprenorphine on human placental aromatase",
abstract = "Methadone and buprenorphine (BUP) are used for treatment of the pregnant opiate addict. CYP19/aromatase is the major placental enzyme responsible for the metabolism of methadone to 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and BUP to norbuprenorphine (norBUP). The aim of this investigation was to determine the effects of methadone and BUP on the activity of placental microsomal aromatase in the conversion of its endogenous substrates testosterone to 17β-estradiol (E2) and 16α-hydroxytestosterone (16-OHT) to estriol (E3). The conversion of testosterone and 16-OHT by human placental microsomes exhibited saturation kinetics, and the apparent Km values were 0.2 ± 1 and 6 ± 3 μM, respectively. Vmax values for E2 and E3 formation were 70 ± 16 and 28 ± 10 pmol/mg protein min, respectively. Also, data obtained revealed that methadone and BUP are competitive inhibitors of testosterone conversion to E2 and 16-OHT to E3. The K i for methadone inhibition of E2 and E3 formation were 393 ± 144 and 53 ± 28 μM, respectively, and for BUP the Ki was 36 ± 9 and 6 ± 1 μM. The higher potency of the two opiates and their metabolites in inhibiting E3 formation is in agreement with the lower affinity of 16-OHT than testosterone to aromatase. Moreover, the metabolites EDDP and norBUP were weaker inhibitors of aromatase than their parent compounds. The determined inhibition constants of methadone and BUP for E3 formation by a cDNA-expressed CYP19 preparation were similar to those for placental microsomes. Therefore, data reported here suggest that methadone, BUP, and their metabolites are inhibitors of androgen aromatization in the placental biosynthesis of estrogens.",
keywords = "Buprenorphine (BUP), CYP19/aromatase, Estrogen formation, Human placenta, Methadone, Pregnant opiate addict",
author = "Zharikova, {Olga L.} and Deshmukh, {Sujal V.} and Tatiana Nanovskaya and Gary Hankins and Mahmoud Ahmed",
year = "2006",
month = "4",
day = "14",
doi = "10.1016/j.bcp.2005.12.035",
language = "English (US)",
volume = "71",
pages = "1255--1264",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - The effect of methadone and buprenorphine on human placental aromatase

AU - Zharikova, Olga L.

AU - Deshmukh, Sujal V.

AU - Nanovskaya, Tatiana

AU - Hankins, Gary

AU - Ahmed, Mahmoud

PY - 2006/4/14

Y1 - 2006/4/14

N2 - Methadone and buprenorphine (BUP) are used for treatment of the pregnant opiate addict. CYP19/aromatase is the major placental enzyme responsible for the metabolism of methadone to 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and BUP to norbuprenorphine (norBUP). The aim of this investigation was to determine the effects of methadone and BUP on the activity of placental microsomal aromatase in the conversion of its endogenous substrates testosterone to 17β-estradiol (E2) and 16α-hydroxytestosterone (16-OHT) to estriol (E3). The conversion of testosterone and 16-OHT by human placental microsomes exhibited saturation kinetics, and the apparent Km values were 0.2 ± 1 and 6 ± 3 μM, respectively. Vmax values for E2 and E3 formation were 70 ± 16 and 28 ± 10 pmol/mg protein min, respectively. Also, data obtained revealed that methadone and BUP are competitive inhibitors of testosterone conversion to E2 and 16-OHT to E3. The K i for methadone inhibition of E2 and E3 formation were 393 ± 144 and 53 ± 28 μM, respectively, and for BUP the Ki was 36 ± 9 and 6 ± 1 μM. The higher potency of the two opiates and their metabolites in inhibiting E3 formation is in agreement with the lower affinity of 16-OHT than testosterone to aromatase. Moreover, the metabolites EDDP and norBUP were weaker inhibitors of aromatase than their parent compounds. The determined inhibition constants of methadone and BUP for E3 formation by a cDNA-expressed CYP19 preparation were similar to those for placental microsomes. Therefore, data reported here suggest that methadone, BUP, and their metabolites are inhibitors of androgen aromatization in the placental biosynthesis of estrogens.

AB - Methadone and buprenorphine (BUP) are used for treatment of the pregnant opiate addict. CYP19/aromatase is the major placental enzyme responsible for the metabolism of methadone to 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and BUP to norbuprenorphine (norBUP). The aim of this investigation was to determine the effects of methadone and BUP on the activity of placental microsomal aromatase in the conversion of its endogenous substrates testosterone to 17β-estradiol (E2) and 16α-hydroxytestosterone (16-OHT) to estriol (E3). The conversion of testosterone and 16-OHT by human placental microsomes exhibited saturation kinetics, and the apparent Km values were 0.2 ± 1 and 6 ± 3 μM, respectively. Vmax values for E2 and E3 formation were 70 ± 16 and 28 ± 10 pmol/mg protein min, respectively. Also, data obtained revealed that methadone and BUP are competitive inhibitors of testosterone conversion to E2 and 16-OHT to E3. The K i for methadone inhibition of E2 and E3 formation were 393 ± 144 and 53 ± 28 μM, respectively, and for BUP the Ki was 36 ± 9 and 6 ± 1 μM. The higher potency of the two opiates and their metabolites in inhibiting E3 formation is in agreement with the lower affinity of 16-OHT than testosterone to aromatase. Moreover, the metabolites EDDP and norBUP were weaker inhibitors of aromatase than their parent compounds. The determined inhibition constants of methadone and BUP for E3 formation by a cDNA-expressed CYP19 preparation were similar to those for placental microsomes. Therefore, data reported here suggest that methadone, BUP, and their metabolites are inhibitors of androgen aromatization in the placental biosynthesis of estrogens.

KW - Buprenorphine (BUP)

KW - CYP19/aromatase

KW - Estrogen formation

KW - Human placenta

KW - Methadone

KW - Pregnant opiate addict

UR - http://www.scopus.com/inward/record.url?scp=33644816100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644816100&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2005.12.035

DO - 10.1016/j.bcp.2005.12.035

M3 - Article

C2 - 16455059

AN - SCOPUS:33644816100

VL - 71

SP - 1255

EP - 1264

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -